title: NICE recommends abiraterone for prostate cancer after manufacturer reduces price.
authors.forename: Zosia
authors.initials: Z
authors.lastname: Kmietowicz
mesh_terms: D000736:Androstenes; D000737:Androstenols / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D004739:England; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000191:economics*; D011788:Quality of Life; D013222:State Medicine / Q000191:economics; D013727:Terminal Care / Q000191:economics*; D014852:Wales
chemical_list: D000736:Androstenes; D000737:Androstenols; C089740:abiraterone